Yildiz, S.Sonmez, G. M.Komuroglu, A. U.Alay, M.2025-05-102025-05-1020231119-30772229-773110.4103/njcp.njcp_1451_212-s2.0-85168813178https://doi.org/10.4103/njcp.njcp_1451_21https://hdl.handle.net/20.500.14720/10444Background:In insulin resistance (IR), it is thought that pancreatic fat accumulation may decrease pancreatic volume, cause an impaired endocrine function, and simultaneously lead to an exocrine dysfunction before diabetes develops. Aim:The association between pancreatic exocrine function and insulin resistance (IR) was assessed in a population with insulin resistance. Method:This was a descriptive cross-sectional study that included 43 IR cases with no other comorbid diseases or pregnancy and 41 healthy controls. Fasting blood adiponectin, leptin, pancreatic amylase, lipase, and stool fecal elastase-1 (FE-1) were studied and compared in both groups. Results:The IR group consisted of 38 females (88.3%) and five males (11.6%), while the control group consisted of 31 females (75.6%) and ten males (24.3%). FE-1 levels were significantly lower in the IR group (P-value <0.01). Blood glucose, insulin, and HbA1c levels were significantly higher in the IR group than in the control (P-value of <0.01, <0.01, <0.01, respectively). Leptin levels were significantly higher in the IR group compared to the controls (P-value = 0.013). After dividing the whole group (n: 84) into two groups as FE-1 <200 & mu;g/g (n: 61) and FE-1 & GE;200 & mu;g/g (n: 23), logistic regression analysis was performed; the significant predictor of low FE-1 was HOMA-IR (ODD ratio: 4.27, P-value <0.01, 95% confidence interval for ODD ratio: 1.95-9.30). Conclusion:This study showed that IR is associated with pancreatic exocrine dysfunction.eninfo:eu-repo/semantics/openAccessFecal Elastase 1Insulin ResistancePancreatic Exocrine DysfunctionArticle268Q4Q21051105637635595WOS:001050229900001